Biologics &
Injectables Index

Convert Unblinded
Payer Perceptions
into Insight

Track current and emerging trends about biologics and injectables with perspectives from payers, HCPs, office managers, representing 75% of Commercial and Medicare lives. Capture unblinded payer perceptions to drive insightful action.

Use the Biologics and Injectables Index to:

  • Examine payer reactions to relevant topics affecting healthcare each quarter
  • Assess high level payer management techniques, site of care dynamics, and administration burden via General Access Topics
  • Receive insight into the power dynamics between IDNs and payers

Learn More About MMIT’s Biologics and Injectables Index

Biologics & Injectables Index helps:

  • Understand which biologic and injectable agents are more commonly prescribed by HCPs and their familiarity with upcoming launches
  • View Practice Manager and HCP perception of administration burden for each brand
  • Uncover patient concerns that are most commonly discussed with their physician when looking for new starts on biologic and injectable therapies or when being forced to switch

Additional Resources

PULSE Checks

View an analysis of a single indication combining insights from Analytics, Message Monitor and Indices, with verbatims from payers and coverage data.


Related Solutions to Support Your Strategy

MMIT offers a variety of payer and IDN insights solutions.